Biomarkers in chronic fatigue syndrome: Evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Fletcher, Mary A ^a,b,c   Zeng, Xiao R ^a,b   Maher, Kevin ^a   Levis, Silvina ^a,b   Hurwitz, Barry ^c   Antoni, Michael ^c   Broderick, Gordon ^d   Klimas, Nancy G ^a,b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Miami Behavioral Health Center   (United States)

^c Department of Biology   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD2 ANTIGEN; CHROMIUM 51; DIPEPTIDYL PEPTIDASE IV; DPP4 PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL FUNCTION; CELL STRAIN K 562; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; CYTOTOXICITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PREDICTION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; T LYMPHOCYTE; ADOLESCENT; BLOOD; ENZYMOLOGY; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIGENS, CD26; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOTOXICITY, IMMUNOLOGIC; FATIGUE SYNDROME, CHRONIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; ROC CURVE; YOUNG ADULT;

EID: 77956283713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010817     Document Type: Article

References (46)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins, et al. (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 121: 953-9.
2. Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, et al. (2003) Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 3(1): 25. Review.
3. Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, et al. (2003) Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 163: 1530-1536.
4. Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, et al. (1999) A community-based study of chronic fatigue syndrome. Arch Intern Med 159: 2129-2137.
5. Chandler HK, Ciccone D, MacBride RJ, Natelson B (2008) Medically unexplained illness in short- and long-term disability applicants: prevalence and cost of salary reimbursement. Disabil Rehabil 30(16): 1185-1191.
6. Reynolds KJ, Vernon SD, Bouchery E, Reeves WC (2004) The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc 2(1): 4.
7. Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S (2008) The economic impact of ME/CFS: Individual and societal costs. Dyn Med 7: 6.
8. Gerrity TR, Bates J, Bell DS, Chrousos G, Furst G, et al. (2003) Chronic fatigue syndrome: what role does the autonomic nervous system play in the pathophysiology of this complex illness? Neuroimmunomodulation 10: 134-141.
9. Hurwitz BE, Coryell VT, Parker M, Martin P, Laperriere A, et al. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin Sci (Lond), 2009 Oct 19;, 118(2): 125-35.
10. Jason LA, Corradi K, Gress S, Williams S, Torres-Harding S (2006) Causes of death among patients with chronic fatigue syndrome. Health Care Women Int 27: 615-26.
11. Levine PH, Peterson D, McNamee FL, O'Brien K, Gridley G, et al. (1992) Does chronic fatigue syndrome predispose to non-Hodgkin's lymphoma? Cancer Res 52(19 Suppl): 5516s-5518s.
12. Evengard B, Jonzon E, Sandberg A, Theorell T, Lindh G, (2003): Differences between patients with chronic fatigue syndrome and with chronic fatigue at an infectious disease clinic in Stockholm, Sweden. Psychiatry Clin Neurosci 57: 361-368.
13. Jason LA, Plioplys AV, Torres-Harding S, Corradi K (2003) Comparing symptoms of chronic fatigue syndrome in a community-based versus tertiary care sample. J Health Psychol 8: 459-64.
14. Klimas NG, Morgan R, Salvado F, Fletcher MA (1990) Immunologic abnormalities of chronic fatigue syndrome. J Clin Microbiol 28: 1403-1410.
15. Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA (1994) Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis 18 Suppl 1: S136-41.
16. Landay AL, Jessop C, Lennette ET, Levy JA (1991) Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 338: 707-712.
17. Maher K, Klimas NG, Fletcher MA (2003) Immunology. In Handbook of Chronic Fatigue edited by Jason LA, Fennell PA, Taylor RR. Hoboken, NJ: John Wiley & Sons. pp 124-151.
18. Lyall M, Peakman M, Wessely S, (2003) A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 55: 79-90. Review.
19. Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, et al. (1987) Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 139: 3306-3313.
20. Maher KJ, Klimas NG, Fletcher MA (2005) Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin Exp Immunol 142: 505-511.
21. Raison CL, Lin JM, Reeves WC (2009) Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun 23: 327-337.
22. Aspler AL, Bolshin C, Vernon SD, Broderick G (2008) Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood. Behav Brain Funct, Sep 26; 4: 44.
23. Siegel SD, Antoni MH, Fletcher MA, Maher K, Segota MC, et al. (2006) Impaired natural immunity, cognitive dysfunction, and physical symptoms in patients with chronic fatigue syndrome: preliminary evidence for a subgroup? J Psychosom Res 60: 559-566.
24. Fletcher MA, Baron G, Fischl M, Klimas NG (1987) Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diag Clin Immunol 5: 69-81.
25. Maher K, Fletcher MA (2006) Quantitative flow cytometry in the clinical laboratory, Clin. Appl Immunol Rev 5: 353-372.
26. Zweig MH, Campbell G (1993) Receiver-Operating Characteristic (ROC) plots: A fundamental evaluation tool in Clin Med Clin Chem. 39: 561-577.
27. Evenga °rd B, Klimas N (2002) Chronic fatigue syndrome: Probable pathogenesis and possible treatments. Drugs 62: 2433-2446.
28. Kogelnik AM, Loomis K, Hoegh-Petersen M, Rosso F, Hischier C, et al. (2006) Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. J Clin Virol 37: Suppl 1: S33-38.
29. Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M, et al. (2005) Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav Immun 19: 91-103.
30. Ledina D, Bradarić N, Milas I, Ivić I, Brncić N, et al. (2007) Chronic fatigue syndrome after Q fever. Med Sci Monit 13: CS88-92.
31. DeFreitas E, Hilliard B, Cheney PR, Bell DS, Kiggundu E, et al. (1991) Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 88: 2922-6.
32. Khan AS, Heneine WM, Chapman LE, Gary HE, Jr., Woods TC, et al. (1993) Folks TM, Schonberger LB. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med 118(4): 241-5.
33. Holmes MJ, Diack DS, Easingwood RA, Cross JP, Carlisle B (1997) Electron microscopic immunocytological profiles in chronic fatigue syndrome. J Psychiatr Res 31: 115-2.
34. Lombardi VC, Ruscetti FW, Gupta JD, Pfost MA, Hagen KS, et al. (2009) Detection of infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
35. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome. PLoS One, 2010 Jan 6; 5(1): e8519.
36. Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, et al. (2006) EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology 346: 205-218.
37. Yang SS, Fu LS, Chang CS, Yeh HZ, Chen GH, et al. (2006) Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol Hepatol 21: 1789-93.
38. Ibegbu CC, Xu YX, Fillos D, Radziewicz H, Grakoui A, et al. (2009) Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection. Immunology 126: 346-53. Epub 2008 Jul 22.
39. Busso N, Wagtmann N, Herling C, Chobaz-Peclat V, Bischof-Delaloye A, et al. (2005) Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol 166: 433-42.
40. Muscat C, Bertotto A, Agea E, Bistoni O, Ercolani R, et al. (1994) Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 98(2): 252-256.
41. Thornberry NA, Gallwitz B (2009) Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) Best Pract Res Clin EndocrinolMetab. 223: 479-486.
42. Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch C (2008) Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes. Vasc Health Risk Manag 4: 753-768.
43. Amori RE, Lau J, Pittas AG (2007) Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 11;298: 194-206.
44. Yan S, Marguet D, Dobers J, Reutter W, Fan H (2003) Deficiency of CD26 results in a change of cytokine and immunoglobulin secretion after stimulation by pokeweed mitogen. Eur J Immunol. 33: 1519-527.
45. Straburzynska-Lupa A, Nowak A, Pilaczynska-Szczesniak L, Straburzynska-Migaj E, Romanowski W, et al. (2010) Visfatin, resistin, hsCRP and insulin resistance in relation to abdominal obesity in women with rheumatoid arthritis. Clin Exp Rheumatol 2010 28(1): 19-24.
46. Fuite J, Vernon SD, Broderick G (2008) Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics 92: 393-399.